Literature DB >> 21067755

Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.

Zenghan Tong1, John E Schiel, Efthimia Papastavros, Corey M Ohnmacht, Quentin R Smith, David S Hage.   

Abstract

Carbamazepine and imipramine are drugs that have significant binding to human serum albumin (HSA), the most abundant serum protein in blood and a common transport protein for many drugs in the body. Information on the kinetics of these drug interactions with HSA would be valuable in understanding the pharmacokinetic behavior of these drugs and could provide data that might lead to the creation of improved assays for these analytes in biological samples. In this report, an approach based on peak profiling was used with high-performance affinity chromatography to measure the dissociation rate constants for carbamazepine and imipramine with HSA. This approach compared the elution profiles for each drug and a non-retained species on an HSA column and control column over a board range of flow rates. Various approaches for the corrections of non-specific binding between these drugs and the support were considered and compared in this process. Dissociation rate constants of 1.7 (±0.2) s(-1) and 0.67 (±0.04) s(-1) at pH 7.4 and 37°C were estimated by this approach for HSA in its interactions with carbamazepine and imipramine, respectively. These results gave good agreement with rate constants that have determined by other methods or for similar solute interactions with HSA. The approach described in this report for kinetic studies is not limited to these particular drugs or HSA but can also be extended to other drugs and proteins.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067755      PMCID: PMC3065503          DOI: 10.1016/j.chroma.2010.10.070

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  28 in total

1.  Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based high-performance liquid chromatography column: interactions of D- and L-tryptophan with immobilized human serum albumin.

Authors:  J Yang; D S Hage
Journal:  J Chromatogr A       Date:  1997-04-04       Impact factor: 4.759

2.  Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin.

Authors:  B Loun; D S Hage
Journal:  Anal Chem       Date:  1996-04-01       Impact factor: 6.986

3.  Determination of the diol content of chromatographic supports by capillary electrophoresis.

Authors:  A Chattopadhyay; D S Hage
Journal:  J Chromatogr A       Date:  1997-01-17       Impact factor: 4.759

4.  Chromatographic analysis of carbamazepine binding to human serum albumin. II. Comparison of the Schiff base and N-hydroxysuccinimide immobilization methods.

Authors:  Hee Seung Kim; Rangan Mallik; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-05-09       Impact factor: 3.205

Review 5.  Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.

Authors:  Giorgio A Ascoli; Enrico Domenici; Carlo Bertucci
Journal:  Chirality       Date:  2006-09       Impact factor: 2.437

Review 6.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

7.  Chromatographic analysis of carbamazepine binding to human serum albumin.

Authors:  Hee Seung Kim; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-02-25       Impact factor: 3.205

8.  Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin.

Authors:  B Loun; D S Hage
Journal:  Anal Chem       Date:  1994-11-01       Impact factor: 6.986

9.  Measurement of drug-protein dissociation rates by high-performance affinity chromatography and peak profiling.

Authors:  John E Schiel; Corey M Ohnmacht; David S Hage
Journal:  Anal Chem       Date:  2009-06-01       Impact factor: 6.986

10.  Studies of imipramine binding to human serum albumin by high-performance affinity chromatography.

Authors:  Michelle J Yoo; Quentin R Smith; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-10       Impact factor: 3.205

View more
  21 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

3.  High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.

Authors:  Michelle J Yoo; David S Hage
Journal:  J Sep Sci       Date:  2011-06-10       Impact factor: 3.645

4.  Chromatographic studies of drug interactions with alpha1-acid glycoprotein by ultrafast affinity extraction and peak profiling.

Authors:  Sandya Beeram; Cong Bi; Xiwei Zheng; David S Hage
Journal:  J Chromatogr A       Date:  2017-03-23       Impact factor: 4.759

Review 5.  Kinetic analysis of drug-protein interactions by affinity chromatography.

Authors:  Cong Bi; Sandya Beeram; Zhao Li; Xiwei Zheng; David S Hage
Journal:  Drug Discov Today Technol       Date:  2015-10-08

6.  Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.

Authors:  Cong Bi; Abby Jackson; John Vargas-Badilla; Rong Li; Giana Rada; Jeanethe Anguizola; Erika Pfaunmiller; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-27       Impact factor: 3.205

7.  Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling.

Authors:  Zenghan Tong; David S Hage
Journal:  J Chromatogr A       Date:  2011-08-17       Impact factor: 4.759

Review 8.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

9.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

Review 10.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.